Medication info
SimvaCo Tablets (Simvastatin)

SimvaCo Tablets (Simvastatin)

Prescription medicationTabletOral
Ingredient · strength
Simvastatin›20mg / 1 tablet
Manufacturer / importer
Donggu Bio Pharmaceutical Co., Ltd.
Appearance
Brownish-yellow oval film-coated tablets
Packaging
30 tablets/bottle, 100 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 200308586 · Notified 2003.11.19 · Insurance code 657302400

Summary

Main use
Improvement of hyperlipidemia, improvement of familial hypercholesterolemia in children, and prevention of cardiovascular disease
Who takes it
Adults · Children
Adult dose
Patients receiving this medicine must follow a standard cholesterol-lowering diet before and during treatment. 1. Reduction of cardiovascular risk Adult patients at high risk of coronary heart disease events because of a history of coronary heart disease, diabetes, peripheral vascular disease, stroke, or other cerebrovascular disease The recommended starting dose is 40 mg of simvastatin once daily. 2. Hyperlipidemia 1) Risk reduction in patients with hypercholesterolemia and coronary heart disease, and hyperlipidemia The usual recommended starting dose of this medicine is 20 mg once daily in the evening. Patients with mild to moderate hypercholesterolemia may start with 10 mg of this medicine. The recommended dose is 5–40 mg of this medicine once daily in the evening. Adjust the dose appropriately according to the initial LDL cholesterol level before starting treatment, the treatment goal, and the patient's response to the medicine. Measure cholesterol levels 4 weeks after starting treatment and periodically thereafter to adjust the dose. Reduce the dose if cholesterol levels fall below the target level. Because of the increased risk of myopathy, including rhabdomyolysis, use of this medicine at a dose of 80 mg, particularly during the first year of treatment, is restricted to patients who have taken 80 mg of this medicine for 12 months or longer without evidence of muscle toxicity (see Precautions for Use, section 1, Warnings). 2) For recommended doses in patients taking this medicine concomitantly with fibrates (excluding gemfibrozil and fenofibrate), amiodarone, verapamil, diltiazem, or amlodipine, and in specific patient groups (i.e., patients with homozygous familial hypercholesterolemia, older adults, and patients with renal impairment), see below (see Precautions for Use, section 6, Interactions). (1) Use in patients with homozygous familial hypercholesterolemia Controlled clinical trial results indicate that patients with homozygous familial hypercholesterolemia should take 40 mg of this medicine once daily in the evening. Administer this medicine in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when other lipid-lowering treatments are not possible. (2) In older adults, a daily dose of 20 mg of this medicine may achieve the maximum reduction in cholesterol levels. (3) Use in patients taking verapamil, diltiazem, or dronedarone When this medicine is coadministered with verapamil, diltiazem, or dronedarone, the dose of this medicine must not exceed 10 mg per day. (4) Use in patients taking amiodarone, amlodipine, or ranolazine When this medicine is coadministered with amiodarone, amlodipine, or ranolazine, the dose of this medicine must not exceed 20 mg per day. (5) Concomitant use with other lipid-lowering agents This medicine is effective when used alone or in combination with a bile acid sequestrant. When this medicine is coadministered with a fibrate (excluding gemfibrozil (see Precautions for Use, section 2, Contraindications) and fenofibrate), the dose of this medicine must not exceed 10 mg per day. (6) Use in patients with renal impairment As this medicine is not substantially excreted by the kidneys, no dose adjustment is necessary in patients with mild to moderate renal impairment. In patients with severe renal impairment, however, start with an initial dose of 5 mg once daily and monitor carefully.
Child dose
Ages 10–17 years: The recommended starting dose of this medicine is 10 mg once daily in the evening. The recommended dose range is 10–40 mg daily, and the recommended maximum dose is 40 mg daily. Adjust the dose for each patient according to the recommended treatment goal. Allow an interval of 4 weeks or longer between dose adjustments.

Ingredients

Manufacturer
Donggu Bio Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of hyperlipidemia, improvement of familial hypercholesterolemia in children, and prevention of cardiovascular disease

  • Coronary heart disease
  • diabetes
  • peripheral vascular disease
  • stroke
  • hypercholesterolemia
  • dyslipidemia
  • dysbetalipoproteinemia
  • hypertriglyceridemia
  • heterozygous familial hypercholesterolemia
View approved original text

This medicine helps lower the risk of cardiovascular diseases. It reduces the risk of cardiovascular events and death in adult patients with a history of coronary heart disease, diabetes, peripheral vascular disease, stroke, or other cerebrovascular diseases. Additionally, it decreases the risk of serious cardiovascular events such as myocardial infarction and stroke, and lowers the risk of vascular surgery. In the treatment of hyperlipidemia, it primarily lowers total cholesterol, LDL cholesterol, Apo-B protein, and triglyceride levels, while increasing good HDL cholesterol levels. It can effectively control cholesterol levels in pediatric patients with familial hypercholesterolemia when used together with dietary therapy. This medicine is used to improve cardiovascular health and reduce the risk of related diseases.

How to take

Adult dose

Patients receiving this medicine must follow a standard cholesterol-lowering diet before and during treatment. 1. Reduction of cardiovascular risk Adult patients at high risk of coronary heart disease events because of a history of coronary heart disease, diabetes, peripheral vascular disease, stroke, or other cerebrovascular disease The recommended starting dose is 40 mg of simvastatin once daily. 2. Hyperlipidemia 1) Risk reduction in patients with hypercholesterolemia and coronary heart disease, and hyperlipidemia The usual recommended starting dose of this medicine is 20 mg once daily in the evening. Patients with mild to moderate hypercholesterolemia may start with 10 mg of this medicine. The recommended dose is 5–40 mg of this medicine once daily in the evening. Adjust the dose appropriately according to the initial LDL cholesterol level before starting treatment, the treatment goal, and the patient's response to the medicine. Measure cholesterol levels 4 weeks after starting treatment and periodically thereafter to adjust the dose. Reduce the dose if cholesterol levels fall below the target level. Because of the increased risk of myopathy, including rhabdomyolysis, use of this medicine at a dose of 80 mg, particularly during the first year of treatment, is restricted to patients who have taken 80 mg of this medicine for 12 months or longer without evidence of muscle toxicity (see Precautions for Use, section 1, Warnings). 2) For recommended doses in patients taking this medicine concomitantly with fibrates (excluding gemfibrozil and fenofibrate), amiodarone, verapamil, diltiazem, or amlodipine, and in specific patient groups (i.e., patients with homozygous familial hypercholesterolemia, older adults, and patients with renal impairment), see below (see Precautions for Use, section 6, Interactions). (1) Use in patients with homozygous familial hypercholesterolemia Controlled clinical trial results indicate that patients with homozygous familial hypercholesterolemia should take 40 mg of this medicine once daily in the evening. Administer this medicine in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when other lipid-lowering treatments are not possible. (2) In older adults, a daily dose of 20 mg of this medicine may achieve the maximum reduction in cholesterol levels. (3) Use in patients taking verapamil, diltiazem, or dronedarone When this medicine is coadministered with verapamil, diltiazem, or dronedarone, the dose of this medicine must not exceed 10 mg per day. (4) Use in patients taking amiodarone, amlodipine, or ranolazine When this medicine is coadministered with amiodarone, amlodipine, or ranolazine, the dose of this medicine must not exceed 20 mg per day. (5) Concomitant use with other lipid-lowering agents This medicine is effective when used alone or in combination with a bile acid sequestrant. When this medicine is coadministered with a fibrate (excluding gemfibrozil (see Precautions for Use, section 2, Contraindications) and fenofibrate), the dose of this medicine must not exceed 10 mg per day. (6) Use in patients with renal impairment As this medicine is not substantially excreted by the kidneys, no dose adjustment is necessary in patients with mild to moderate renal impairment. In patients with severe renal impairment, however, start with an initial dose of 5 mg once daily and monitor carefully.

Child dose

Ages 10–17 years: The recommended starting dose of this medicine is 10 mg once daily in the evening. The recommended dose range is 10–40 mg daily, and the recommended maximum dose is 40 mg daily. Adjust the dose for each patient according to the recommended treatment goal. Allow an interval of 4 weeks or longer between dose adjustments.

Precautions

This medication may cause myopathy or rhabdomyolysis, which can affect muscles. The risk is particularly increased at high doses, and caution is necessary. Patients with allergies to this medication or liver diseases, as well as women who are pregnant or breastfeeding, should not take this medication. Furthermore, the risk may increase when combined with certain medications; therefore, consultation with a physician is essential. Regular testing is required if there is a history of liver disease or suspected liver dysfunction as this medication can affect liver function. Any unusual symptoms should be reported to healthcare providers immediately. If symptoms such as muscle pain or weakness occur, the medication should be stopped immediately and a physician should be consulted, particularly for elderly patients or those with poor kidney function who need to be more cautious. This medication may interact with other drugs, so patients should inform healthcare providers of its use before starting any new medication. Women of childbearing potential should practice contraception while using this medication, and if pregnancy is confirmed, discontinuation should occur immediately. This medication is not to be used in children under 10 years of age; for adolescents over the age of 10, it should be taken only under a physician's guidance. In case of overdose, immediate medical attention should be sought for appropriate treatment. Store this medication out of the reach of children and it is safest to store it in its original container.

Side effects

  • Myopathy
  • rhabdomyolysis
  • abdominal pain
  • weakness
  • constipation
  • diarrhea
  • dyspepsia
  • bloating
  • nausea
  • headache
Show 85 more
  • upper respiratory infection
  • edema
  • atrial fibrillation
  • gastritis
  • diabetes mellitus
  • myalgia
  • insomnia
  • dizziness
  • bronchitis
  • sinusitis
  • eczema
  • urinary tract infection
  • muscle cramps
  • arthralgia
  • immune-mediated necrotizing myopathy
  • specific cranial nerve dysfunction
  • tremors
  • paresthesia
  • peripheral neuropathy
  • peripheral nerve paralysis
  • mental disorders
  • anxiety
  • sleep disturbances
  • depression
  • cognitive impairment
  • myasthenia gravis
  • ocular myasthenia gravis
  • hepatitis
  • liver dysfunction
  • jaundice
  • pancreatitis
  • liver failure
  • gall bladder-related jaundice
  • hepatic steatosis
  • liver cirrhosis
  • fulminant hepatic necrosis
  • liver cancer
  • loss of appetite
  • vomiting
  • alopecia
  • pruritus
  • skin changes
  • lichen planus-like drug rash
  • gynecomastia
  • decreased libido
  • sexual dysfunction
  • progression of cataracts
  • ophthalmoplegia
  • anemia
  • elevated aminotransferases
  • elevated ALP
  • elevated γ-GTP
  • increased bilirubin level
  • thyroid dysfunction
  • elevated serum creatine kinase
  • interstitial lung disease
  • anaphylaxis
  • angioedema
  • lupus-like syndrome
  • polymyositis
  • dermatomyositis
  • vasculitis
  • purpura
  • thrombocytopenia
  • leukopenia
  • hemolytic anemia
  • positive antinuclear antibodies
  • increased erythrocyte sedimentation rate
  • eosinophilia
  • arthritis
  • urticaria
  • photosensitivity
  • fever
  • chills
  • flushing
  • fatigue
  • dyspnea
  • toxic epidermal necrolysis
  • Stevens-Johnson syndrome
  • erythema multiforme
  • limb sensory impairment
  • paresthesia
  • cold sensation
  • thrombocytopenia
  • interstitial lung disease

Not everyone experiences these, and they can vary from person to person.

Storage

This medication must be stored in a tightly sealed container to protect it from air exposure, and it should be kept at room temperature between 1°C and 30°C. Proper storage will maintain the effectiveness of the medication and prevent degradation.

Appearance and packaging

Appearance

Brownish-yellow oval film-coated tablets

Package unit

30 tablets/bottle, 100 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.